Mounjaro (tirzepatide): uses, dosage, side effects, and price in India
Mounjaro (tirzepatide) is an injectable medicine from Eli Lilly that is used once a week. In India, it is approved for the management of type 2 diabetes as well as for chronic weight management in eligible adults with obesity or overweight with at least one weight-related medical condition.1,4 It is a Schedule H medicine, meaning it can only be bought with a prescription. It is available as single-dose vials and pre-filled KwikPens, with an MRP ranging from approximately ₹3,281 to ₹25,781 per month depending on its dose.
Prescription required. Mounjaro is a Schedule H medicine and is available only with a valid doctor's prescription. At PharmEasy, every prescription is verified by a pharmacist before the medicine is shipped.
GLP-1 medicines are prescription-only. A doctor can tell you whether one is appropriate for you and at what dose.
Consult a doctor Or take the eligibility self-checkQuick facts
What is Mounjaro?
Mounjaro is the brand name for tirzepatide. It is a once-weekly injectable medicine given under the skin. It belongs to a newer class of medicines that works by activating two natural gut hormone receptors: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Together, these help improve blood sugar control and support long-term weight management (see what Mounjaro is approved for in India).
In India, Mounjaro is marketed by Eli Lilly and is approved for the management of type 2 diabetes and chronic weight management in eligible adults alongside lifestyle changes.1,4 Your doctor will determine whether it is suitable for your condition.
Tirzepatide is also available in India under the brand name Yurpeak, which is the same Eli Lily Tirzepatide marketed by Cipla in India and manufactured by Eli Lilly and distributed by Cipla. Both brands contain the same active ingredient, and your doctor may prescribe either based on availability and your treatment plan. You can learn more about the medicine on our tirzepatide molecule page.
Note: Mounjaro is intended to be used alongside a healthy diet, regular physical activity, and other treatments recommended by your doctor. It is designed for long-term management (not as a shortcut) and should always be used under medical supervision.
How Mounjaro works
Unlike most GLP-1 medicines, which act only on the GLP-1 receptor, tirzepatide works on both the GIP and GLP-1 receptors.4 This helps improve blood sugar control and supports weight management through several mechanisms by activating these two receptors. It helps your body:5
release more insulin when blood sugar levels are high
reduce the amount of sugar released by the liver
slow stomach emptying (helps you feel full for longer)
reduce appetite and food cravings
Because tirzepatide targets two hormone pathways instead of one, clinical trials have generally shown greater average weight loss with tirzepatide than with semaglutide (which acts only on the GLP-1 receptor). This has been evaluated in the SURMOUNT and STEP clinical trial programmes, including head-to-head studies.2 However, individual results vary and depend on factors such as your health condition, dose, treatment adherence, and lifestyle. Your doctor will monitor your progress and adjust the treatment plan as needed.
What Mounjaro is approved for in India
In India, Mounjaro is approved for two indications:1,4
To improve blood sugar control in adults, along with a healthy diet, regular physical activity, and, when needed, other diabetes medicines (if needed).
As an adjunct to a reduced-calorie diet and increased physical activity for adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related medical condition.
Obesity is now recognised as a chronic disease that often requires long-term management. In December 2025, the World Health Organization (WHO) published its first guideline recommending the use of GLP-1 receptor agonists as part of obesity care for eligible adults (see above).3 This reflects the growing recognition that obesity is a chronic medical condition rather than simply a lifestyle issue.
Although Mounjaro is approved for these uses, it may not be suitable for everyone. In general, GLP-1-based medicines are considered for adults with a BMI of 30 kg/m² or higher, or 27 kg/m² or higher with at least one weight-related medical condition, but the decision to prescribe Mounjaro depends on your overall health, medical history, and your doctor's clinical assessment. If you are unsure whether you're eligible, consult a doctor to find out.
Mounjaro strengths and prices in India
Mounjaro is available in India as single-dose vials and pre-filled KwikPens. The vial contains one weekly dose, while each KwikPen contains four once-weekly doses. The prices below are the Maximum Retail Price (MRP) as of August 2026 and may change over time. So, always check the latest price on the product page before purchasing or placing an order.
Mounjaro dosage and titration
Mounjaro is injected once a week (preferably on the same day each week) with or without food. Treatment usually starts with a low dose, which is gradually increased to help your body adjust and reduce the risk of side effects. Here's what you need to know:
Treatment typically begins with 2.5 mg once weekly. This is an initiation dose to help improve tolerability and is not intended for long-term blood sugar control or weight management.
If needed, the dose may be increased gradually depending on the response and side effects (strictly under your doctor's supervision) until the most suitable maintenance dose is reached.
The dose that is right for you depends on your goals, response, and also on how well you are tolerating the medicine. Your doctor will decide if and when your dose should be adjusted.
Side effects of Mounjaro
Like all medicines, Mounjaro may also cause side effects, although not everyone might experience them. The most common side effects affect the digestive system and are usually more noticeable when you first start treatment or after your dose is increased. They often improve as your body adjusts to the medicine.
These are usually mild to moderate and often improve over time:4
Note: Eating smaller meals, eating slowly, and staying well hydrated may help reduce these side effects. You can also read our guide on managing GLP-1 side effects.
Although less common, some side effects require prompt medical attention. Contact your doctor immediately if you experience:
Seek medical help right away if you have severe or persistent stomach pain (a sign of possible pancreatitis), signs of an allergic reaction, or symptoms of very low blood sugar (shakiness, sweating, confusion).
Suspected adverse reactions can also be reported through the Pharmacovigilance Programme of India (PvPI).
Who should not take Mounjaro
Mounjaro may not be suitable for everyone. So, before starting treatment, tell your doctor about your medical history and any medicines you are taking currently. It is generally not recommended if you:4
You should also tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Note: Inform them if you have kidney disease, gallbladder disease, diabetic eye disease, or if you take other diabetes medicines such as insulin or sulfonylureas, as your treatment may need to be adjusted.
How to get Mounjaro in India legally
Mounjaro is a Schedule H prescription medicine and cannot be purchased over the counter. To obtain it safely, follow these steps:1,4
Your doctor will assess whether Mounjaro is suitable for your condition and whether it should be prescribed for type 2 diabetes or chronic weight management.
Mounjaro should only be prescribed by a qualified doctor and used under medical supervision.
Submit your valid prescription when ordering. Your prescription will be verified before the medicine is dispensed and shipped using an appropriate cold-chain process.
PharmEasy dispenses only 100% genuine, cold-chain-shipped medicines from licensed pharmacies. Counterfeit GLP-1 medicines have been reported in India. To reduce the risk of receiving a fake product, always purchase Mounjaro from a licensed pharmacy using a valid prescription. Before using the medicine, check that the packaging is sealed and verify the batch number and expiry date. Avoid buying GLP-1 medicines from unverified websites, social media, or unauthorised sellers.
If you're unsure whether Mounjaro is right for you, consult a doctor. Only they can tell you whether a GLP-1 medicine suits your health and issue a prescription if appropriate. If prescribed, purchase it only from a licensed pharmacy (check Mounjaro on PharmEasy) with a valid prescription.
Consult a doctorStoring Mounjaro in Indian conditions
Mounjaro is a biological medicine that must be stored correctly to maintain its effectiveness. Proper storage is especially important in hot climates.
Refrigerate at 2°C to 8°C. Store Mounjaro in the main compartment of the refrigerator. Do not freeze it. If the medicine has been frozen, it should not be used.4
Unopened Mounjaro may be stored at room temperature for a limited period under the conditions specified in the package leaflet.
Protect from heat and light. Keep the medicine in its original carton and away from direct sunlight or excessive heat.
During travel, carry it in an insulated pouch with a gel pack. Avoid placing it directly on ice and keep it in your hand luggage when flying.
Keep out of the sight and reach of children.
Mounjaro vs alternatives
Mounjaro is one of several medicines available in India for type 2 diabetes and chronic weight management. The most appropriate treatment plan depends on your medical condition, goals, and your doctor's recommendation.
Both contain tirzepatide as the active ingredient. Mounjaro is marketed by Eli Lilly, while Yurpeak is manufactured by Eli Lilly and distributed by Cipla. Your doctor may prescribe either brand depending on availability and your treatment plan.
Mounjaro contains tirzepatide, a dual GIP/GLP-1 receptor agonist, whereas Wegovy contains semaglutide, a GLP-1 receptor agonist approved for chronic weight management. See our detailed Mounjaro vs Wegovy comparison.
Ozempic contains semaglutide and is approved in India for the management of type 2 diabetes. Our detailed comparison in the Mounjaro vs Ozempic guide explains how it differs from Mounjaro.
Note: The best treatment plan varies from person to person. Your doctor will recommend the most appropriate option based on your health, medical history, and health goals.
Educational tools to help you prepare for a conversation with your doctor. None of them prescribe or recommend a medicine.
Frequently asked questions
References
The information provided in this GLP-1 Library is intended solely to educate and inform users about GLP-1 medicines, their uses, benefits, risks, and other relevant considerations. The purpose of this content is to help users make informed decisions and have meaningful discussions with their healthcare professional. PharmEasy does not intend to promote or recommend any specific medicine, brand or treatment.
The information provided is for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment, and should not be considered a substitute for consultation with a qualified doctor or other healthcare professional. Before starting, stopping, or changing any medication or treatment, please consult your doctor or qualified healthcare professional. Your doctor can assess your individual health needs and determine whether a GLP-1 medicine is appropriate for you.